A detailed history of First Republic Investment Management, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 30,603 shares of BCRX stock, worth $215,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,603
Previous 29,294 4.47%
Holding current value
$215,139
Previous $206,000 4.85%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$6.71 - $7.92 $8,783 - $10,367
1,309 Added 4.47%
30,603 $216,000
Q2 2023

Jul 28, 2023

BUY
$6.96 - $8.81 $121,500 - $153,796
17,457 Added 147.48%
29,294 $206,000
Q1 2023

May 11, 2023

BUY
$7.94 - $11.84 $93,985 - $140,150
11,837 New
11,837 $98,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.31B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.